Immuno-oncology targets
TARGET | DISEASE INDICATIONS | STATUS – KEY DATA | MILESTONE |
---|---|---|---|
ZM008
Lead Molecule |
Prostate Cancer, B cell lymphoma, glioma, rheumatoid arthritis |
|
IND filing in Q2 2020 |
ZM012
mAb target. Functions through tumour associated antigen/NK cell receptor |
Lymphoma and other Undisclosed indications | Unique Clone identification in process | Target identity in Q4 2019 |
ZM014
mAb target. Functions through tumour NK cell receptor |
Lymphoma | Unique Clone identification in process | Target identity in Q4 2019 |
2
Molecules for NK cell and cell targets under development
Future targets of interest